Department of Nephrology, Dialysis and Transplantation, ULiège Academic Hospital, Liège, Belgium.
Department Groupe Interdisciplinaire de Géno-protéomique Appliquée, Cardiovascular Sciences, ULiège, Liège, Belgium.
Kidney360. 2021 Feb 12;2(4):639-652. doi: 10.34067/KID.0006992020. eCollection 2021 Apr 29.
Kidney damage has been reported in patients with COVID-19. Despite numerous reports about COVID-19-associated nephropathy, the factual presence of the SARS-CoV-2 in the renal parenchyma remains controversial.
We consecutively performed 16 immediate (≤3 hours) renal biopsies in patients diagnosed with COVID-19. Kidney samples from five patients who died from sepsis not related to COVID-19 were used as controls. Samples were methodically evaluated by three pathologists. Virus detection in the renal parenchyma was performed in all samples by bulk RNA RT-PCR (E and N1/N2 genes), immunostaining (2019-nCOV N-Protein), fluorescence hybridization (nCoV2019-S), and electron microscopy.
The mean age of our COVID-19 cohort was 68.2±12.8 years, most of whom were male (69%). Proteinuria was observed in 53% of patients, whereas AKI occurred in 60% of patients. Acute tubular necrosis of variable severity was found in all patients, with no tubular or interstitial inflammation. There was no difference in acute tubular necrosis severity between the patients with COVID-19 versus controls. Congestion in glomerular and peritubular capillaries was respectively observed in 56% and 88% of patients with COVID-19, compared with 20% of controls, with no evidence of thrombi. The 2019-nCOV N-Protein was detected in proximal tubules and at the basolateral pole of scattered cells of the distal tubules in nine out of 16 patients. hybridization confirmed these findings in six out of 16 patients. RT-PCR of kidney total RNA detected SARS-CoV-2 E and N1/N2 genes in one patient. Electron microscopy did not show typical viral inclusions.
Our immediate kidney samples from patients with COVID-19 highlight a congestive pattern of AKI, with no significant glomerular or interstitial inflammation. Immunostaining and hybridization suggest SARS-CoV-2 is present in various segments of the nephron.
已有报道称 COVID-19 患者存在肾损伤。尽管有大量关于 COVID-19 相关肾病的报道,但 SARS-CoV-2 确实存在于肾实质中这一事实仍存在争议。
我们连续对 16 例确诊为 COVID-19 的患者进行了即时(≤3 小时)肾活检。另外,还使用了 5 例因与 COVID-19 无关的败血症而死亡患者的肾脏样本作为对照。由 3 位病理学家对样本进行系统评估。通过 bulk RNA RT-PCR(E 和 N1/N2 基因)、免疫组化(2019-nCOV N-Protein)、荧光原位杂交(nCoV2019-S)和电子显微镜对肾实质中的病毒进行检测。
COVID-19 组患者的平均年龄为 68.2±12.8 岁,大多数为男性(69%)。53%的患者存在蛋白尿,60%的患者出现 AKI。所有患者均存在不同程度的急性肾小管坏死,无肾小管或间质炎症。COVID-19 患者与对照组之间的急性肾小管坏死严重程度无差异。与对照组的 20%相比,56%的 COVID-19 患者的肾小球和肾小管周围毛细血管充血,88%的患者出现充血,无血栓证据。在 16 例患者中有 9 例在近端肾小管和散在的远端肾小管基底部检测到 2019-nCOV N-Protein。在 16 例患者中有 6 例通过杂交确认了这些发现。1 例患者的肾总 RNA 的 RT-PCR 检测到 SARS-CoV-2 E 和 N1/N2 基因。电子显微镜未显示出典型的病毒包涵体。
我们从 COVID-19 患者的即时肾活检样本中发现,急性肾损伤呈充血模式,肾小球和间质无明显炎症。免疫组化和杂交提示 SARS-CoV-2 存在于肾单位的不同节段。